GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Duopharma Biotech Bhd (XKLS:7148) » Definitions » 3-Year Revenue Growth Rate

Duopharma Biotech Bhd (XKLS:7148) 3-Year Revenue Growth Rate : 4.50% (As of Sep. 2023)


View and export this data going back to 2002. Start your Free Trial

What is Duopharma Biotech Bhd 3-Year Revenue Growth Rate?

Duopharma Biotech Bhd's Revenue per Share for the three months ended in Sep. 2023 was RM0.18.

During the past 12 months, Duopharma Biotech Bhd's average Revenue per Share Growth Rate was -1.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was 4.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was 6.10% per year. During the past 10 years, the average Revenue per Share Growth Rate was 12.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Duopharma Biotech Bhd was 22.80% per year. The lowest was 3.10% per year. And the median was 6.90% per year.


Competitive Comparison of Duopharma Biotech Bhd's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Duopharma Biotech Bhd's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Duopharma Biotech Bhd's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Duopharma Biotech Bhd's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Duopharma Biotech Bhd's 3-Year Revenue Growth Rate falls into.



Duopharma Biotech Bhd 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Duopharma Biotech Bhd  (XKLS:7148) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Duopharma Biotech Bhd 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Duopharma Biotech Bhd's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Duopharma Biotech Bhd (XKLS:7148) Business Description

Traded in Other Exchanges
N/A
Address
Lot 2599, Jalan Seruling 59, Kawasan 3, Taman Klang Jaya, Klang, MYS, 41200
Duopharma Biotech Bhd is an investment holding company engaged in manufacturing pharmaceuticals. It develops, manufactures, and markets generic and over-the-counter pharmaceutical products. The operating segment of the company is the manufacturing and distribution of pharmaceutical products. The principal activities of its subsidiary are to carry out business as a manufacturer, distributor, importer and exporter of pharmaceutical products and medicines.

Duopharma Biotech Bhd (XKLS:7148) Headlines

No Headlines